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x-linked adrenoleukodystrophy  
in heterozygous female patients:  
women are not just carriers
Adrenoleucodistrofia ligada ao X em pacientes femininas heterozigotas:  
mulheres não são meras portadoras
Charles Marques Lourenço1, Gustavo Novelino Simão2, Antonio Carlos Santos3, Wilson Marques Jr4
X-linked adrenoleukodystrophy (X-ALD) is an 
X-linked recessive disorder that affects the brain white 
matter and that is associated with adrenal insufficien-
cy1. The disease most commonly affects boys during early 
childhood and initially presents with either adrenal in-
sufficiency or a variety of neurological manifestations, 
such as hyperkinetic behavior, neurological regression, 
sensorineural deafness and optic atrophy, although 
most patients eventually develop the whole neurologi-
cal picture. As white matter demyelination relentless-
ly progresses, the neurological status steadily becomes 
worse, resulting in complete disability, vegetative state, 
and death. Adrenomyeloneuropathy (AMN), a less severe 
clinical manifestation2, causes progressive myelopathy 
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ABSTRACT
X-linked adrenoleukodystrophy (X-ALD) is a recessive X-linked disorder associated with marked phenotypic variability. Female carriers are 
commonly thought to be normal or only mildly affected, but their disease still needs to be better described and systematized. Objectives: To 
review and systematize the clinical features of heterozygous women followed in a Neurogenetics Clinic. Methods: We reviewed the clinical, 
biochemical, and neuroradiological data of all women known to have X-ADL. Results: The nine women identified were classified into three 
groups: with severe and aggressive diseases; with slowly progressive, spastic paraplegia; and with mildly decreased vibratory sensation, brisk 
reflexes, and no complaints. Many of these women did not have a known family history of X-ALD. Conclusions: Heterozygous women with X-
ADL have a wide spectrum of clinical manifestations, ranging from mild to severe phenotypes.
Key words: adrenoleukodystrophy, X-linked disorder, heterozygous carriers.
ReSumo
A adrenoleucodistrofia ligada ao X (ADL-X) é uma doença recessiva ligada ao X, associada à grande variabilidade clínica. Mulheres hetero-
zigotas portadoras do gene causador da doença são consideradas, tradicionalmente, como clinicamente normais ou com fenótipo clínico 
muito discreto. No entanto, a apresentação clínica deste grupo necessita ser melhor caracterizada e sistematizada. Objetivos: Revisar e 
sistematizar as principais características clínicas de mulheres heterozigotas para ADL-X, seguidas em serviço de neurogenética. Métodos: 
Foram revisados os principais achados clínicos, bioquímicos e neurorradiológicos das mulheres seguidas no serviço com o diagnóstico 
bioquímico de ADL-X. Resultados: Nove mulheres foram identificadas e classificadas em três grupos: com doença grave e incapacitante; 
com evolução mais insidiosa e sintomas de paraparesia espástica; e com sintomas discretos apresentando diminuição da sensibilidade vi-
bratória, reflexos vivos, mas sem queixas clínicas. A maioria dessas mulheres não possuía história familiar positiva para ALD-X. Conclusões: 
Mulheres heterozigotas para ALD-X apresentam um amplo espectro de manifestações clínicas, variando desde um fenótipo leve, subclínico 
até apresentações graves e incapacitantes. 
Palavras-Chave: adrenoleucodistrofia, doença recessiva ligada ao X, portadoras heterozigotas.
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that predominantly affects the corticospinal tract in the 
lower limbs of adolescents and young adult males. This 
condition is frequently mistakenly diagnosed as multiple 
sclerosis (MS)3. In such patients, the presence of adrenal 
dysfunction strongly suggests AMN4.
Although women carriers are usually considered nor-
mal or only very mildly affected, it has, in fact, been ob-
served that at least half of the heterozygous females pres-
ent neurological manifestations that vary in severity from 
mild hyperreflexia and vibratory sense impairment, with 
little or no functional disability to severe spastic parapare-
sis that requires a wheelchair5. As in males, females show 
no correlation between clinical severity and very long 
chain fatty acids (VLCFA) blood levels6. It seems, however, 
that there is a correlation between the skewing of the X 
chromosome and the specific mutation harbored by the 
patient6. Adrenal insufficiency has also been rarely detect-
ed in heterozygotes5-7. 
To date, there are no systematic studies that address the 
prevalence of neurological and adrenal dysfunctions in ALD 
female heterozygotes. Additionally, their clinical characteris-
tics have not been properly documented. In this report, we 
review the clinical features of the heterozygous women who 
were followed in our Neurogenetics Division, Clinics Hospital, 
School of Medicine of Ribeirão Preto, University of São Paulo, 
Ribeirão Preto, in São Paulo.
meTHoDS
In this study, we have included all females with VLCFA 
profiles showing increased C26:C22 and C24:C22, regard-
less of their clinical status or family history, followed in our 
hospital. They were submitted to a detailed clinical exami-
nation, nerve conduction studies (NCS), and brain/spinal 
cord magnetic resonance imaging (MRI). They all provided 
an informed consent (Clinics Hospital, School of Medicine of 
Ribeirão Preto, n. 3172/2009).
ReSulTS
Nine women showed abnormal VLCFA profiles compat-
ible with a heterozygous state for X-ALD. 
Their clinical manifestations suggest the existence of 
three distinct groups (Table): with a severe and aggressive 
neurological disease, mimicking the male X-ALD phenotype; 
with a slowly progressive spastic paraparesis; and with no 
complaints, having only mild abnormalities detected on neu-
rological examination, including decreased vibratory sensa-
tion and brisk reflexes, with no apparent progression. There 
was no difference between the three groups with respect to 
the biochemical profile. 
The first group consisted of three patients who present-
ed with neurological regression and white mater abnormali-
ties. They exhibited mental impairment, cerebellar ataxia, 
and spastic paraplegia. Psychotic behavior was noted in the 
most severely affected girl, who also presented seizures. Two 
patients presented learning disabilities before the physical 
manifestations onset. The brain MRI of patient 1 was virtually 
identical to the pattern found in males with ALD of childhood 
onset (Fig 1). Patient 2 was initially diagnosed with childhood 
onset MS and was treated accordingly (Fig 2).
In the second group, four patients showed spastic para-
paresis as the main symptom. Two of them were mother and 
daughter, who were initially diagnosed as having autosomal 
dominant hereditary spastic paraplegia. The daughter’s man-
ifestations appeared in the second decade of life, whereas the 
mother developed symptoms in her forties. In this group, 
the symptoms were slowly progressive, but they were con-
sidered debilitating mainly due to the presence of bladder in-
continence. Mood disorder was observed in three patients. 
Interestingly, only one patient had a known family history 
(son and brother) of ADL. Their brain MRI was initially nor-
mal, but mild abnormalities of the subcortical white matter 
were later developed.
In the third group, two patients were diagnosed exclu-
sively due to their positive family history. They both reported 
Table. Manifestations of heterozygous females with X-ALD.
Characteristics
Patients
01 02 03 04 05 06 07 08 09
Age of onset 7y 10y 12y 41y 20y 32y 41y 30y 35y
Dementia + + + - - - - - -
Gait disturbance + + + + + + + - -
Hyperreflexia in legs + + + + + + + + +
Distal sensory impairment + + + + + + + + +
Clinical fluctuation - - - - - - - - -
Adrenal insufficiency - - - - - - - - -
Abnormal NCS - - - - - - - - -
Abnormal BAER - - - - - - - - -
Brain MRI abnormalities + + + + + - +
Abnormal spinal cord MRI - - - - - - - - -
NCS: nerve conduction studies; BAER: brainstem auditory evoked response; MRI: magnetic resonance imaging.
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Fig 1. Characteristic patterns of symmetrical enhanced T-2 signal in the parieto-occipital region with contrast enhancement, 
similar to the one found in boys with the classical cerebral form of X-ALD.
A B C
Fig 2. Severe periventricular demyelination with enhancement after contrast. This patient was misdiagnosed as childhood form of 
multiple sclerosis.
A
D e F G
B C
490 Arq Neuropsiquiatr 2012;70(7):487-491
1. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis 
and therapy. Brain 1997;120:1485-1508.
2. Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with 
Addison’s disease: adult variant of adreno-leukodystrophy. J Neurol 
1976;213:237-250. 
3. Dooley JM, Wright BA. Adrenoleukodystrophy mimicking multiple 
sclerosis. J Can Sci Neurol 1985;12:73-74. 
4. Blevins Jr LS, Shankroff J, Moser HW, Ladenson PW. Elevated 
plasma adrenocorticotropin concentration as evidence of limited 
adrenocortical reserve in patients with adrenomyeloneuropathy. J 
Clin Endocrinol Metab 1994;78:261-265. 
5. Powers JM, Moser HW, Moser AB, Ma CK, Elias SB, Norum RA. 
Pathologic findings in adrenoleukodystrophy heterozygotes. Arch 
Pathol Lab Med 1987;111:151-153. 
6. Maier EM, Kammerer S, Muntau AC, Wichers M, Braun A, Roscher AA. 
Symptoms in carriers of adrenoleukodystrophy relate to skewed X 
inactivation. Ann Neurol 2002;52:683-688.
7. Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of 
adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 
1991;13:254-261. 
8. O’Brien TJ, Gates PG, Byrne E. Symptomatic female heterozygotes 
for adrenoleukodystrophy: a report of two unrelated cases and 
References
“cramps” and occasional discomfort when walking long dis-
tances. On examination, vibration was mildly decreased dis-
tally in the lower limbs, and tendon jerks were brisk at knees 
and ankles. 
Karyotype (G-banding) analysis was performed in these 
patients, but no abnormalities were found in 100 metaphases. 
Endocrinological, ophthalmological, and audiometric evalu-
ations, NCS and spinal cord MRIs were all normal.
DiSCuSSioN
The phenotype of X-ALD varies widely among affected 
patients, even within the same family, but five major clini-
cal subtypes have been identified in affected males8. These 
include childhood cerebral ALD, the most common pheno-
type, which affects 48% of male patients under 11 years-old; 
AMN, the next most common form (26%), which affects men 
over 21 years-old; the adolescent cerebral form (5%), which 
is observed between the ages of 11 to 21 years; Addison’s dis-
ease without neurological involvement (11%); and the adult 
cerebral form (3%). Additionally, there are reports of a rare ol-
ivopontocerebellar atrophy presentation that affects mainly 
adults with late-onset manifestations of X-ADL9. 
Neurological manifestations in ALD heterozygous fe-
males were previously thought to be relatively uncom-
mon. However, data from the Kennedy Institute10 showed 
that 15 to 20% of these patients develop symptomatic 
spastic paraparesis. In addition, neurological examination 
of these women showed that almost 55% of them had at 
least mild neurological abnormalities. This spectrum of 
manifestations resembled our patients from the first and 
second groups. Such manifestations were somewhat simi-
lar to males with AMN but were milder, slowly progressive, 
and of late onset. Adrenal dysfunction was extremely rare 
in female patients.
In our patients, stiffness and clumsiness in the legs 
were usually the first symptoms to appear (90%). The most 
common clinical signs were hyperreflexia (100%), spastic 
paraparesis (76%), and impaired sense of vibration (88%). 
Neuropathy was not observed in our series of patients, al-
though it was presented in other series11. Two of our patients 
from the second group developed a late and incapacitating 
sphincter disturbance. Cerebral involvement is considered 
uncommon in female carriers12, but three of our patients pre-
sented cerebral demyelination, and two developed severe 
neurological regression. Fluctuating manifestations and ad-
renal dysfunction were not observed in our cohort5. 
The diagnosis of ALD is rarely made in women without 
an affected male relative. It is possible that many patients are 
initially misdiagnosed as having MS, until a family history of 
ALD is detected3. Interestingly, only three women in our co-
hort had a positive family history, suggesting that women, 
even those with mild evidence of bilateral corticospinal tract 
and/or decreased vibration perception in the lower limbs, 
should have their VLCFA levels tested.
Brain MRI identify characteristic changes in the majority 
of males with ALD and in about 50% of those with AMN, and 
may even detect abnormalities in asymptomatic patients13. A 
total of 16% of symptomatic females may present white mat-
ter abnormalities in the internal capsule, cerebral peduncle, 
and optic radiation10. In general, our patients showed only 
very mild abnormalities; although those with serious neuro-
logical regression showed multiple areas of cerebral demyeli-
nation (Fig 1 and 2). In our patients, MRI of the spinal cord 
was always normal, in opposition to previous reports suggest-
ing that a decreased spinal cord diameter could be a marker 
of the onset of symptoms in heterozygous females12.
At present, there is no proven prevention or curative 
therapy for ALD in female carriers, and none of our patients 
received a specific therapy14. In addition to a supportive fol-
low-up with no unnecessary investigation, a proper genetic 
counseling may be extremely useful for these patients and 
their families15. The wide range of clinical variability, which 
seems to be associated with ADL female carriers, should 
prompt interested clinical investigators to organize a multi-
center systematic study to better define the associated clini-
cal spectrum.
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